Global Gastric Cancer Diagnostics Market to 2032
Overview
The Global Gastric Cancer Diagnostics Market is expected to reach a 2.08 USD Billion by 2032 and is projected to grow at a CAGR of 10.90% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.15
Forecast, 2032 (USD Billion)
2.08
CAGR, 2024 - 2032
10.90%
Report Coverage
Global
Global Gastric Cancer Diagnostics Market 2018-2032 USD Billion
Global Gastric Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.15 USD Billion
- Projected Market Size (2032): 2.08 USD Billion
- CAGR (2025-2032): 10.90%
Key Findings of Global Gastric Cancer Diagnostics Market
- The Global Gastric Cancer Diagnostics Market was valued at 1.15 USD Billion in 2024.
- The Global Gastric Cancer Diagnostics Market is likely to grow at a CAGR of 10.90% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 0.73 USD Billion
- The fastest growing segment Stool in Sample Type Segment grew Fastest with a CAGR of 13.90% during the forecast period from 2024 to 2032.
Global Gastric Cancer Diagnostics Market Scope
Global Gastric Cancer Diagnostics Market Segmentation & Scope
Diagnostic Type
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
Age Group
- pediatric
- Adult
- Geriatrics
Disease Type
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
Stage
- Stage 0
- Stage III
- Stage II
- Stage I
Product Type
- Services
- Instruments
- Reagents & Consumables
Gender
- Female
- Male
Sample Type
- Urine
- Blood
- Tissue
- Stool
End User
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Global Gastric Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.15 USD Billion |
| Market Value in 2032 | 2.08 USD Billion |
| CAGR (2025-2032) | 10.90% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Diagnostic Type,Age Group,Disease Type,Stage,Product Type,Gender,Sample Type,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Global, leading in terms of revenue 1.15 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 429.75 USD Million in 2024.
Segments and Scope
-
Global Gastric Cancer Diagnostics Market to 2032, By Diagnostic Type
- Confirmatory Test is the largest segment in Global Gastric Cancer Diagnostics Market to 2032 with a revenue of 666.58 USD Billion in the year 2024.
- Confirmatory Test is the Fastest growing segment in Global Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.90 % in forecast period 2025-2032.
-
Global Gastric Cancer Diagnostics Market to 2032, By Age Group
- Geriatrics is the largest segment in Global Gastric Cancer Diagnostics Market to 2032 with a revenue of 618.91 USD Billion in the year 2024.
- Geriatrics is the Fastest growing segment in Global Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.13 % in forecast period 2025-2032.
-
Global Gastric Cancer Diagnostics Market to 2032, By Disease Type
- Intestinal or Diffuse Adinocarcinoma is the largest segment in Global Gastric Cancer Diagnostics Market to 2032 with a revenue of 463.95 USD Billion in the year 2024.
- Intestinal or Diffuse Adinocarcinoma is the Fastest growing segment in Global Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.43 % in forecast period 2025-2032.
-
Global Gastric Cancer Diagnostics Market to 2032, By Stage
- Stage I is the largest segment in Global Gastric Cancer Diagnostics Market to 2032 with a revenue of 435.91 USD Billion in the year 2024.
- Stage I is the Fastest growing segment in Global Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.39 % in forecast period 2025-2032.
-
Global Gastric Cancer Diagnostics Market to 2032, By Product Type
- Reagents & Consumables is the largest segment in Global Gastric Cancer Diagnostics Market to 2032 with a revenue of 643.31 USD Billion in the year 2024.
- Reagents & Consumables is the Fastest growing segment in Global Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.82 % in forecast period 2025-2032.
-
Global Gastric Cancer Diagnostics Market to 2032, By Gender
- Male is the largest segment in Global Gastric Cancer Diagnostics Market to 2032 with a revenue of 619.66 USD Billion in the year 2024.
- Male is the Fastest growing segment in Global Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.86 % in forecast period 2025-2032.
-
Global Gastric Cancer Diagnostics Market to 2032, By Sample Type
- Stool is the largest segment in Global Gastric Cancer Diagnostics Market to 2032 with a revenue of 470.27 USD Billion in the year 2024.
- Stool is the Fastest growing segment in Global Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.90 % in forecast period 2025-2032.
-
Global Gastric Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in Global Gastric Cancer Diagnostics Market to 2032 with a revenue of 411.47 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Global Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.89 % in forecast period 2025-2032.
-
Global Gastric Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Global Gastric Cancer Diagnostics Market to 2032 with a revenue of 733.63 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Global Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.90 % in forecast period 2025-2032.
Global Gastric Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| BIOMÉRIEUX | |||
| Abbott | |||
| General Electric | |||
| F. Hoffmann-La Roche Ltd. | |||
Global Gastric Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion
Global Gastric Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Global Gastric Cancer Diagnostics Market is segmented based on Segmentation Diagnostic Type,Age Group,Disease Type,Stage,Product Type,Gender,Sample Type,End User,Distribution Channel.
Global Gastric Cancer Diagnostics Market was valued at USD 1.15(Revenue in USD Billion) in 2020.
Global Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 10.90% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Global Gastric Cancer Diagnostics Market, holding a largest market share of 0.73 USD Billion in 2024
Global Gastric Cancer Diagnostics Market Scope
Global Gastric Cancer Diagnostics Market Segmentation & Scope
Diagnostic Type
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
Age Group
- pediatric
- Adult
- Geriatrics
Disease Type
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
Stage
- Stage 0
- Stage III
- Stage II
- Stage I
Product Type
- Services
- Instruments
- Reagents & Consumables
Gender
- Female
- Male
Sample Type
- Urine
- Blood
- Tissue
- Stool
End User
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Frequently Asked Questions
The Global Gastric Cancer Diagnostics Market is segmented based on Segmentation Diagnostic Type,Age Group,Disease Type,Stage,Product Type,Gender,Sample Type,End User,Distribution Channel.
Global Gastric Cancer Diagnostics Market was valued at USD 1.15(Revenue in USD Billion) in 2020.
Global Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 10.90% during the forecast period of 2024 to 2032.
The estimated market value of the Global Gastric Cancer Diagnostics Market for final year is USD 2.08 (USD Billion).
Global Gastric Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Global Gastric Cancer Diagnostics Market is segmented based on Segmentation Diagnostic Type,Age Group,Disease Type,Stage,Product Type,Gender,Sample Type,End User,Distribution Channel.
Global Gastric Cancer Diagnostics Market was valued at USD 1.15(Revenue in USD Billion) in 2020.
Global Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 10.90% during the forecast period of 2024 to 2032.
The estimated market value of the Global Gastric Cancer Diagnostics Market for final year is USD 2.08 (USD Billion).
CHOOSE LICENCE TYPE
- 7000.00
- 4800.00
- 3200.00
- 8000.00
- 15000.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.